The Impact of Glycemic Index on Sleep and Memory Consolidation

March 8, 2024 updated by: Dr Hayley Young, Swansea University
The study will test whether the consumption of a low versus a high glycemic index pre-bed drink influences sleep architecture, memory consolidation, nocturnal glucose metabolism, and mood.

Study Overview

Detailed Description

Few studies have examined the impact of meal composition on sleep. Most research has focused on carbohydrate intake, although reports are sporadic and confounded by the manipulation of other macronutrients. Nonetheless, the pattern of results appears to depend on the nature of the sleep variable under investigation e.g., latency, duration, or efficiency. The study will determine whether manipulating the glycemic index of a pre-bed drink influences sleep architecture, procedural and declarative memory consolidation, nocturnal glucose metabolism, and mood.

Participants will stay in the sleep laboratory for three nights, each night separated by one week (visit 1, 2, and 3). The first night is an acclimatisation night. The same procedure will be followed on all three nights, as described below.

On the morning of each visit, a continuous glucose monitor will be set up and worn until 8pm the following evening. Participants will be asked to return to the sleep laboratory at 7pm, having fasted for five hours, and asked to consume a standardised evening meal. Several mood questionnaires will be completed throughout the evening and a polysomnography will be set up. Two memory tasks will be administered at approximately 10pm. Immediately after this, participants will consume either water (night 1), or a low glycemic index or high glycemic index drink (night 2 or 3). Participants will retire to bed at approximately 11pm and woken up between 6.30am - 8am, depending on personal preference.

In the morning, the memory tasks will be administered again, as well as two mood questionnaires. Participants will be asked to wear a Pro-Diary watch throughout the day, which measures mood and hunger. At 8pm, both the continuous glucose monitor and Pro-diary watch will be collected from the participant.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Glamorgan
      • Swansea, West Glamorgan, United Kingdom, SA2 8PP
        • Swansea University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male (given that the menstrual cycle may influence sleep polysomnography)
  • Good health
  • Not taking any medication known to effect sleep or metabolism
  • Normal sleep duration (i.e. between 6.5 - 9 hours of sleep per night)
  • A sleep efficiency score above 80% (Pittsburg Sleep Quality Index)
  • Normal sleep schedule (i.e. fall asleep between 10pm and 12pm)
  • No difficulty sleeping in new places

Exclusion Criteria:

  • Diagnosis of any physical or mental disorder e.g. diabetes, cardiovascular disorders, gastrointestinal disorders, sleep problems, epilepsy, or mood disorders
  • Unhealthy weight (BMI over 30)
  • Drink more than 300mg of caffeine per day (3 - 4 standard sized 8-oz cups)
  • Work nights or shifts
  • Smoke/vape
  • Regularly drink alcohol (>3 glasses per day)
  • Used recreational drugs within the last 6 months
  • Take part in >3 hours of vigorous exercise per week
  • Any known food allergies or intolerances
  • Nocturnal eating or regular consumption of alcohol before bed (assessed by the Meal Pattern Questionnaire)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low glycemic index drink
Fruit drink containing low glycemic index sugar.
Fruit flavoured drink with low glycemic index sugar (300 ml)
Experimental: High glycemic index drink
Fruit drink containing high glycemic index sugar.
Fruit flavoured drink with high glycemic index sugar (300 ml)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep onset latency (polysomnography)
Time Frame: Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Onset of sleep from the time the lights are turned off.
Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Total sleep time (polysomnography)
Time Frame: Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
The total number of hours of sleep.
Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Wake after sleep onset (polysomnography)
Time Frame: Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Hours of wake time after three epochs of sleep have occurred.
Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Sleep efficiency (polysomnography)
Time Frame: Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Total sleep time divided by the time from lights out until awakening in the morning.
Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Sleep stages (polysomnography)
Time Frame: Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Time spent in each sleep stage.
Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Arousal index (polysomnography)
Time Frame: Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Number of arousals throughout the night.
Bedtime (approx. 11.00pm) to wake time (approx 7.30am)
Leeds Sleep Evaluation Questionnaire
Time Frame: Administered 10 - 20 minutes after waking up in the morning,
Subjective assessment of sleep quality. Scores range from 0 to 30. Higher scores indicate poorer sleep quality.
Administered 10 - 20 minutes after waking up in the morning,

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose response (continuous glucose monitor)
Time Frame: 25 hours during night 2 and night 3 (weeks 2 and 3)
The 2h and 3h incremental area under the curve (iAUC) will be used to assess glycemic response to the pre-bed drink. The mean amplitude of glycemic excursion (MAGE) will be assessed as an indicator for glycemic variability during the night and for 25 hours.
25 hours during night 2 and night 3 (weeks 2 and 3)
Finger tapping task (procedural memory)
Time Frame: Completed at 10pm, and between 6.30 - 8am the following morning, on night 2 and night 3 (week 2 and 3).
The change in performance from the learning phase to the recall phase.
Completed at 10pm, and between 6.30 - 8am the following morning, on night 2 and night 3 (week 2 and 3).
Story recall task (declarative memory)
Time Frame: Completed at 10pm, and between 6.30 - 8am the following morning, on night 2 and night 3 (week 2 and 3).
The number of content words (nouns, adjectives, and verbs) correctly recalled.
Completed at 10pm, and between 6.30 - 8am the following morning, on night 2 and night 3 (week 2 and 3).
Epworth Sleepiness Scale
Time Frame: Administered at 8pm on the evening after night 2 and night 3 (week 2 and 3).
Subjective assessment of daytime sleepiness. Scores range from 0 - 24. Higher scores indicate more daytime sleepiness.
Administered at 8pm on the evening after night 2 and night 3 (week 2 and 3).
Mood and hunger
Time Frame: Completed five times throughout the evening and twice in the morning (immediately after waking up and 20-30 minutes later) on night 2 and night 3 (week 2 and 3). .
Scores range from 0 - 100. Higher scores indicate stronger feelings.
Completed five times throughout the evening and twice in the morning (immediately after waking up and 20-30 minutes later) on night 2 and night 3 (week 2 and 3). .
Mood
Time Frame: Prompted from 9.30am - 5.30pm after night 2 and night 3 (week 2 and 3).
Pro-diary watch
Prompted from 9.30am - 5.30pm after night 2 and night 3 (week 2 and 3).
Actigraphy
Time Frame: Night 2 and night 3 (week 2 and 3).
Time spent in each sleep stage.
Night 2 and night 3 (week 2 and 3).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hayley Young, Swansea University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 31, 2022

Primary Completion (Actual)

April 30, 2023

Study Completion (Actual)

April 30, 2023

Study Registration Dates

First Submitted

July 15, 2022

First Submitted That Met QC Criteria

October 20, 2022

First Posted (Actual)

October 24, 2022

Study Record Updates

Last Update Posted (Actual)

March 12, 2024

Last Update Submitted That Met QC Criteria

March 8, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SSSU

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

Clinical Trials on Low glycemic index drink

Subscribe